Showing results (11-20 of 132) with videos related to
Sort By:
Pageof 14
Future Medicinal Chemistry|July 29, 2014
Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseasesSalvatore Bongarzone, Matteo Staderini, Maria Laura BolognesiACS Pharmacology & Translational Science|March 20, 2025
Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat TauopathiesElisa Uliassi, Maria Laura Bolognesi, Andrea MilelliSub-Cellular Biochemistry|September 26, 2025
New Therapeutic Modalities in Prion DiseasesAlberto Pettinari, Elisa Uliassi, Maria Laura BolognesiExpert Opinion on Drug Discovery|July 5, 2019
Novel screening approaches for human prion diseases drug discoveryFabio Moda, Maria Laura Bolognesi, Giuseppe LegnameAdvanced Drug Delivery Reviews|May 30, 2025
Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targetingDionysis Kampasis, Elisa Uliassi, Maria Laura BolognesiJournal of Medicinal Chemistry|April 29, 2016
From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer's Disease?Maria Laura Bolognesi, Annachiara Gandini, Federica Prati, et al.Journal of Medicinal Chemistry|March 20, 2025
Medicinal Chemistry: A Key Driver in Achieving the Global Sustainable Development GoalsBianca Martinengo, Eleonora Diamanti, Elisa Uliassi, et al.Journal of Pharmaceutical and Biomedical Analysis|May 26, 2009
Investigation of the photostability properties of memoquin, a quinone derivative for the treatment of Alzheimer's diseaseFrancesca Mancini, Maria Laura Bolognesi, Carlo Melchiorre, et al.Journal of Medicinal Chemistry|July 28, 2017
BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's DiseaseFederica Prati, Giovanni Bottegoni, Maria Laura Bolognesi, et al.Chemmedchem|September 14, 2023
Click Chemistry and Targeted Degradation: A Winning Combination for Medicinal Chemists?Anna Pasieka, Eleonora Diamanti, Elisa Uliassi, et al.Pageof 14